Logo1

Mirzaev KB, Fedorinov DS, Ivashchenko DV, Sychev DA.
ADME pharmacogenetics: future outlook for Russia.
Pharmacogenomics. 2019 Aug 1.


doi: 10.2217/pgs-2019-0013.

 

скачать материал

Zastrozhin MS, Skryabin VY, Miroshkin SS, Bryun EA, Sychev DA.
Pharmacogenetics of alcohol addiction: current perspectives.
The Application of Clinical Genetics 2019, 12:131-140

DOI https://doi.org/10.2147/TACG.S206745

скачать материал

Mirzaev KB, Samsonova KI, Potapov PP, Andreev DA, Grishina EA, Ryzhikova KA, Sychev DA.
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel.
Mol Biol Rep. 2019 May 17.

 

doi: 10.1007/s11033-019-04871-y. [Epub ahead of print]

скачать материал

 

Zastrozhin M, Skryabin V, Smirnov V, Grishina E, Ryzhikova K, Chumakov E, Sychev D, Bryun E.
Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder.
Can J Physiol Pharmacol. 2019 May

скачать материал

17. doi: 10.1139/cjpp-2019-0177. [Epub ahead of print]

Sychev DA, Abdullaev SP, Mirzaev KB, Ryzhikova KA, Shuyev GN, Sozaeva ZA, Grishina EA, Mammaev SN, Gafurov DM, Kitaeva EY, Shprakh VV, Suleymanov SS, Bolieva LZ, Sozaeva MS, Zhuchkova SM, Gimaldinova NE, Sidukova EE, Asoskova AV, Mumladze RB.
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
Mol Biol Rep. 2019 Mar 8. doi: 10.1007/s11033-019-04722-w. [Epub ahead of print]

 

скачать материал